MARKET

INSP

INSP

Inspire Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

207.57
-15.41
-6.91%
After Hours: 207.57 0 0.00% 18:03 12/03 EST
OPEN
224.75
PREV CLOSE
222.98
HIGH
224.75
LOW
205.75
VOLUME
258.19K
TURNOVER
--
52 WEEK HIGH
286.29
52 WEEK LOW
159.18
MARKET CAP
5.68B
P/E (TTM)
-119.6852
1D
5D
1M
3M
1Y
5Y
Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Conference
MINNEAPOLIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructiv...
GlobeNewswire · 11/17 13:00
Macquarie Group Ltd Buys Dover Corp, Amphenol Corp, Inspire Medical Systems Inc, Sells ...
GuruFocus News · 11/12 22:38
Inspire Medical Systems Offers Update On 2022 Amublatory Surgical Center Reimbursement Levels
Inspire Medical Systems, Inc. (NYSE:INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with
Benzinga · 11/10 22:51
Inspire Medical updates on new 2022 CMS Reimbursement rates for its procedures
Inspire Medical Systems (NYSE:INSP) is trading ~4.0% higher in the post-market after the company commented on the reimbursement rates published by the Centers for Medicare and Medicaid Services (CMS). Included in newly released
Seekingalpha · 11/10 22:06
Inspire Medical Systems, Inc. Provides Update on 2022 Ambulatory Surgical Center Reimbursement Levels
MINNEAPOLIS, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructiv...
GlobeNewswire · 11/10 21:28
Wells Fargo Maintains Overweight on Inspire Medical Systems, Raises Price Target to $305
Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $250 to $305.
Benzinga · 11/03 11:31
--Lake Street Adjusts Price Target on Inspire Medical Systems to $320 From $260, Maintains Buy Rating
MT Newswires · 11/03 10:10
SVB Leerink Maintains Outperform on Inspire Medical Systems, Raises Price Target to $325
SVB Leerink analyst Danielle Antalffy maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $300 to $325.
Benzinga · 11/03 09:28
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INSP. Analyze the recent business situations of Inspire Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
33.33%Buy
33.33%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average INSP stock price target is 301.30 with a high estimate of 325.00 and a low estimate of 261.00.
High325.00
Average301.30
Low261.00
Current 207.57
EPS
Actual
Estimate
-0.53-0.40-0.26-0.13
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 311
Institutional Holdings: 28.63M
% Owned: 104.66%
Shares Outstanding: 27.36M
TypeInstitutionsShares
Increased
84
1.91M
New
33
653.38K
Decreased
97
1.77M
Sold Out
28
355.83K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.83%
Healthcare Equipment & Supplies
-0.90%
Key Executives
Chairman/Independent Director
Marilyn Nelson
President/Chief Executive Officer/Director
Timothy Herbert
Chief Financial Officer
Richard Buchholz
Chief Operating Officer
Philip Ebeling
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Bryan Phillips
Vice President/Director of Human Resources
Steven Jandrich
Other
Randall Ban
Independent Director
Shelley Broader
Independent Director
Gary Ellis
Independent Director
Georgia Garinois- Melenikiotou
Independent Director
Jerry Griffin
Independent Director
Shawn McCormick
Independent Director
Dana Mead
Independent Director
Casey Tansey
No Data
About INSP
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The therapy is indicated for patients with moderate to severe OSA who do not have significant central sleep apnea and do not have a complete concentric collapse of the airway at the soft palate level. The Company sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization.

Webull offers kinds of Inspire Medical Systems Inc stock information, including NYSE:INSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INSP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INSP stock methods without spending real money on the virtual paper trading platform.